2020-05-13 07:00:00
REGISTER
Valatine, Hannah

Hannah Valantine, MD

State-of-the-Art Plenary Lecture

Title: NIH’s Scientific Approach to Inclusive Excellence

Hannah Valantine is the first NIH Chief Officer for Scientific Workforce Diversity, and a Senior Investigator in the Intramural Research Program at the National Heart, Lung, and Blood Institute. Prior to starting this position in April 2014, Dr. Valantine was Professor of Cardiovascular Medicine and the Senior Associate Dean for Diversity and Leadership at Stanford, a leadership position she held since November 2004. She is nationally recognized for her transformative approaches to diversity and is a recipient of the NIH Director’s Pathfinder Award for Diversity in the Scientific Workforce. She is currently leading NIH efforts to promote diversity through innovation across the NIH-funded biomedical workforce through a range of evidence-based approaches. Dr. Valantine maintains an active clinical research program that continues to have high impact on patient care. Current research extends her previous finding that an organ transplant is essentially a genome transplant, and that monitoring the level of donor DNA in a recipient’s blood as a marker of organ damage will detect early stages of rejection. She is currently overseeing a multi-site consortium of mid-Atlantic transplant centers to validate these findings clinically toward the development of a non-invasive tool for detecting early signs of organ rejection.

 

Other Speakers

2019-10-16_1107_DiazLuis Diaz, MD
2019-04-12 Werth Portraits-64Victoria Werth, MD
Lumpkin, EllenEllen Lumpkin, PhD
HeadshotWilson Liao, MD
Garza headshot 2019Luis Garza, MD/PhD
Dr. Valentina GrecoValentina Greco, PhD
Nunez4x6Gabriel Nunez, MD
5x5GrinnellFrederick Grinnell, PhD
Bulletin Spring 2005: Zhijian Chen, University of Texas Southwestern Medical Center at Dallas - Dallas, TX / Bulletin Sep 2005: Researchers have discovered a surprise lurking inside mitochondria, the power plants that are present in every cell. It turns out that these powerhouses also contain a protein that triggers the immune system to attack viral invaders. According to the researchers, the new role makes perfect biological and evolutionary sense because it fits well with another function of mitochondria as executioners of a biochemical cascade that causes programmed cell death, or apoptosis. "This is the first protein known to be involved in the immune response that is found in mitochondria," said Zhijian "James" Chen, an HHMI investigator at the University of Texas Southwestern Medical Center. Chen and his colleagues reported the discovery on August 25, 2005, in an immediate early publication of the journal Cell.Zhijian (James) Chen, PhD
AlicePPentland,MD (2)Alice Pentland, MD
Ezhkova PictureElena Ezhkova, PhD
© 2020 Society for Investigative Dermatology, All rights reserved.